HTFL - NASDAQ
Heartflow, Inc. Common Stock
$29.54
+2.4%HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
At a Glance
Live Snapshothtfl
Cash at Beginning of Period
Last Annual Value
51.52M
3-Year CAGR
8%
5-Year CAGR
5%
10-Year CAGR
2%
Heartflow, Inc. Common Stock Competitors Analysis of Cash at Beginning of Period
| Company | Cash at Beginning of Period | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Heartflow, Inc. Common Stock NASDAQ:HTFL | 51.52M | 7.9% | N/A | N/A | |
 Perrigo Company plc NYSE:PRGO | 558.80M | -2.4% | -2.4% | 3.0% | |
 Travere Therapeutics, Inc. NASDAQ:TVTX | 58.53M | -1.7% | -7.1% | 4.5% | |
 Privia Health Group, Inc. NASDAQ:PRVA | 491.15M | 12.2% | 42.1% | N/A | |
 Disc Medicine, Inc. NASDAQ:IRON | 192.67M | -0.4% | 49.4% | N/A | |
 Surgery Partners, Inc. NASDAQ:SGRY | 269.50M | -1.6% | -3.3% | 16.6% | |
 Legend Biotech Corporation NASDAQ:LEGN | 286.82M | -28.5% | -8.8% | N/A | |
 Tarsus Pharmaceuticals, Inc. NASDAQ:TARS | 97.38M | 10.8% | -10.3% | N/A | |
 Alphatec Holdings, Inc. NASDAQ:ATEC | 138.84M | 17.9% | 5.2% | 28.6% |
Heartflow, Inc. Common Stock Fair Value Envelope
Related Guides
Continue your HTFL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.